NDC 23155-062

NDC 23155-062

NDC 23155-062 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 23155-062
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 23155-062-10 [23155006210]

Theophylline TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA090430
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-11-01
Marketing End Date2018-01-10

NDC 23155-062-05 [23155006205]

Theophylline TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA090430
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-11-01
Marketing End Date2018-01-10

NDC 23155-062-01 [23155006201]

Theophylline TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA090430
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-11-01
Marketing End Date2018-01-10

NDC 23155-062-03 [23155006203]

Theophylline TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA090430
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-11-01
Marketing End Date2018-01-10

Drug Details

Medicade Reported Pricing

23155062102 CALCIUM ACETATE 667 MG TABLET

Pricing Unit: EA | Drug Type:

23155006201 THEOPHYLLINE ER 300 MG TAB

Pricing Unit: EA | Drug Type:
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.